Cellectar Biosciences Inc...

NASDAQ: CLRB · Real-Time Price · USD
0.36
-0.05 (-11.79%)
At close: Jun 06, 2025, 3:13 PM
-11.79%
Bid 0.28
Market Cap 16.59M
Revenue (ttm) n/a
Net Income (ttm) -24.54M
EPS (ttm) -0.63
PE Ratio (ttm) -0.57
Forward PE -0.74
Analyst Buy
Ask 0.36
Volume 8,108,167
Avg. Volume (20D) 11,529,825
Open 0.39
Previous Close 0.41
Day's Range 0.34 - 0.40
52-Week Range 0.22 - 3.42
Beta 0.52

About CLRB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CLRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 day ago
-11.61%
Cellectar Biosciences shares are trading lower. Th... Unlock content with Pro Subscription
2 days ago
+66.32%
Cellectar Biosciences shares are trading higher after the company announced it was granted FDA Breakthrough Therapy Designation status for Iopofosine I-131.